Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Central Nervous System Tumors
  •  General Oncology
  •  Radiation Oncology
  •  Prostate Cancer
  •  Gynecological Cancers
  •  Paediatric Cancers
  •  Melanoma/Skin Cancer
  •  Kidney Cancer


Citation: Clin Oncol. 2020;5(1):1758.DOI: 10.25107/2474-1663.1758

Large Neuroendocrine Tumor in a Patient with Acromegaly Case Report

Martins FPR, Rocha JA, de Oliveira LCS, Távora F, Porto VC, de Oliveira GSGC, Montenegro CR and Mota JIS

Department of Pulmonology, Federal University of Ceará, Brazil
Department of Oncology, Federal University of Ceará, Brazil
Department of Thoracic Surgery, Federal University of Ceará, Brazil
Department of Pathology, Federal University of Ceará, Brazil
Department of Endocrinology, Federal University of Ceará, Brazil
UFC, Brazil

*Correspondance to: Filadelfia PR Martins 

 PDF  Full Text Case Report | Open Access


The case of a patient with a rare malignancy whose incidence ranges from 0.2 to 2/100,000 individuals. The increase in incidence probably showed increasing changes in diagnosis. Approximately 25% of these tumors grow in the lungs and represent 2% of all lung tumors. Of all bronchial NETs, only 5% are associated with Multiple type 1 Endocrine Neoplasms (MEN-1). According to the current WHO classification of 2015, neuroendocrine lung cancer should be classified into typical carcinoids, atypical carcinoids, large cell neuroendocrine carcinoma or small cell carcinoma, the classification being based on histological morphology. The commonly associated endocrine syndromes are inadequate secretion of the natriuretic hormone, Cushing's syndrome and, rarely, acromegaly. We report a case of a male patient with a large neuroendocrine tumor associated with a pituitary macroadenoma. Laboratory tests on admission were changed, GH of 56.5 ng/mL (Ref <5 ng/mL), IGF-1 of 1304.4 ng/mL (Ref- 96.4 - 227.8 ng/mL), chromogranin 4.89 (Ref 3.00), b-HCG-negative. The patient was initially submitted to thoracic surgery and subsequently underwent neurological surgery in another center, so that he was accompanied by professionals from various areas, making
it increasingly evident the need for hospitals to have centers for the study of these neuroendocrine tumors.


Acromegaly; Lung cancer; Adenoma pituitary; MEN-1

Cite the Article:

Martins FPR, Rocha JA, de Oliveira LCS, Távora F, Porto VC, de Oliveira GSGC, et al. Large Neuroendocrine Tumor in a Patient with Acromegaly Case Report. Clin Oncol. 2020;5:1758..

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Dosimetric Comparison of IMRT, Hybrid IMRT and Hybrid VMAT for Early Stage Right-Sided Breast Cancer
 Abstract  PDF  Full Text
Outcome of Allogeneic Bone Marrow Transplantation for Acute Myeloid Leukemia Following Single Agent Induction with Hypomethylation
 PDF  Full Text
View More...